US Stock MarketDetailed Quotes
CPMD CANNAPHARMARX INC
- 0.010500
- +0.000500+5.00%
15min DelayClose Aug 16 16:00 ET
6.96MMarket Cap1.05P/E (TTM)
0.010600High0.010000Low437.95KVolume0.010500Open0.010000Pre Close4.45KTurnover0.07%Turnover Ratio1.05P/E (Static)662.50MShares0.02790052wk High-0.40P/B6.83MFloat Cap0.00000152wk Low--Dividend TTM650.50MShs Float0.279000Historical High--Div YieldTTM6.00%Amplitude0.000001Historical Low0.010000Avg Price1Lot Size
CANNAPHARMARX INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 11.31%-427.62K | 10.28%-548.83K | -57.04%-2.27M | -19.51%-1.3M | -62.27%123.88K | -55.52%-482.17K | -63.05%-611.74K | 40.02%-1.45M | -233.49%-1.09M | 131.83%328.33K |
| Net income from continuing operations | 385.29%5.36M | -729.38%-11.72M | 143.24%3.69M | 307.31%7.54M | 57.03%-564.37K | -24.78%-1.88M | 31.83%-1.41M | 3.41%-8.53M | 50.39%-3.64M | -27.55%-1.31M |
| Operating gains losses | -1,254.26%-7.29M | 4,672.68%7.36M | -563.74%-6.64M | -79,079.14%-7.04M | -175.55%-379.23K | 1,816.03%631.35K | -82.97%154.19K | -71.12%1.43M | -100.14%-8.9K | -19.17%501.96K |
| Depreciation and amortization | 952.38%64.24K | 295.49%23.04K | -56.65%127.85K | -230.97%-96.06K | 812.30%211.97K | -96.91%6.1K | 518.47%5.83K | 10,791.21%294.93K | 9,525.33%73.35K | 2,973.41%23.24K |
| Other non cash items | --733.72K | 254.96%576.42K | 5.05%1.29M | 155.38%119.64K | 69.45%1.01M | --0 | -50.54%162.39K | -19.14%1.23M | -171.69%-216.04K | 146.41%594.34K |
| Change In working capital | -120.33%-145.29K | -38.40%218.33K | -120.80%-821.2K | -166.77%-1.77M | -124.77%-118.09K | 78.60%714.71K | -15.00%354.42K | 1,037.87%3.95M | 1,164.64%2.65M | 149.58%476.81K |
| -Change in receivables | -1,425.46%-185.08K | -272.60%-23.63K | -77.25%-38.27K | -13.30%-7.21K | -264.04%-12.59K | -58.06%-12.13K | -54.76%-6.34K | -1,672.82%-21.59K | -3,375.41%-6.36K | -975.70%-3.46K |
| -Change in inventory | ---527.62K | ---30.98K | ---1.13M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | --0 | --0 | 200.00%68.54K | --0 | 99.33%-367 | 546.51%74.83K | ---5.92K | -151.91%-68.54K | -98.08%3.21K | -127.04%-54.99K |
| -Change in payables and accrued expense | -78.03%134.52K | -24.35%272.94K | -93.23%276.3K | -121.42%-631.12K | -122.52%-65.56K | 11.80%612.2K | 21.02%360.78K | 839.93%4.08M | 6,773.52%2.95M | 124.98%291.1K |
| -Change in other current assets | --0 | --0 | 113.26%5.91K | --0 | 97.69%-135 | -100.00%136 | 100.10%5.91K | ---44.55K | ---38.72K | ---5.84K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---39.44K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11.31%-427.62K | 10.28%-548.83K | -57.04%-2.27M | -19.51%-1.3M | -62.27%123.88K | -55.52%-482.17K | -63.05%-611.74K | 40.02%-1.45M | -233.49%-1.09M | 131.83%328.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 30.49%-80.63K | 80.75%-1.75K | 90.95%-4.18K | -67.29%-73.81K | 94.61%-893 | -123.50%-116K | -29,293.55%-9.11K | -108.56%-46.19K |
| Net PPE purchase and sale | --0 | --0 | 30.49%-80.63K | 80.75%-1.75K | 90.95%-4.18K | -67.29%-73.81K | 94.61%-893 | -121.76%-116K | -29,293.55%-9.11K | -108.56%-46.19K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 30.49%-80.63K | 80.75%-1.75K | 90.95%-4.18K | -67.29%-73.81K | 94.61%-893 | -123.50%-116K | -29,293.55%-9.11K | -108.56%-46.19K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -7.80%424.67K | 13.57%560.27K | 67.54%2.35M | 35.96%1.31M | 121.32%92.69K | 27.25%460.6K | -4.45%493.31K | 4.79%1.4M | 320.15%961.19K | -216.69%-434.72K |
| Net issuance payments of debt | -7.80%424.67K | -4.22%472.5K | 143.20%2.35M | 62.20%727.44K | 1,073.76%672.07K | 540.11%460.6K | -4.45%493.31K | 88.11%967.69K | 332.19%448.49K | -493.47%-69.02K |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 50.14%437.01K | --0 | --147K |
| Proceeds from stock option exercised by employees | --0 | --87.77K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -7.80%424.67K | 13.57%560.27K | 67.54%2.35M | 35.96%1.31M | 121.32%92.69K | 27.25%460.6K | -4.45%493.31K | 4.79%1.4M | 320.15%961.19K | -216.69%-434.72K |
| Net cash flow | ||||||||||
| Beginning cash position | --12.09K | -71.95%650 | -91.66%2.32K | --0 | --0 | --0 | -91.66%2.32K | -91.71%27.77K | -93.35%7.5K | -95.30%5.18K |
| Current changes in cash | 96.91%-2.95K | 109.59%11.44K | 98.96%-1.67K | 100.47%650 | 239.20%212.38K | -1,321.85%-95.38K | -195.84%-119.32K | 72.50%-159.66K | -41.42%-139.39K | -27.60%-152.57K |
| Effect of exchange rate changes | --0 | --0 | --0 | ---- | ---- | 215.89%95.38K | 261.18%117.01K | -50.91%134.21K | ---- | ---- |
| End cash Position | --9.15K | --12.09K | -71.95%650 | -71.95%650 | --0 | --0 | --0 | -91.66%2.32K | -91.66%2.32K | -93.35%7.5K |
| Free cash flow | 23.09%-427.62K | 10.41%-548.83K | -50.55%-2.36M | -18.68%-1.31M | -57.58%119.7K | -56.98%-555.98K | -56.38%-612.63K | 35.38%-1.56M | -236.24%-1.1M | 127.35%282.14K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg